The FDA just approved Viramune (nevirapine)

July 1996

The FDA just approved Viramune (nevirapine)...the FIFTH new antiviral for HIV in just the last 6 months.

Viramune is the first drug in a new class called non-nucleoside reverse transcriptase inhibitors (NNRTIs). It inhibits the same enzyme as AZT...but it works in a different way.

Experts don't yet know exactly how to use this drug.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote